Shama Moktan, Ph.D. - Related publications

2011 The University of Mississippi Medical Center 
NOTE: We are testing a new system for identifying relevant work based on semantic analysis that identifies similarities between recently published papers and the current author's publications. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches.
50 most relevant papers in past 60 days:
Year Citation  Score
2020 Jose G, Lu YJ, Hung JT, Yu AL, Chen JP. Co-Delivery of CPT-11 and Panobinostat with Anti-GD2 Antibody Conjugated Immunoliposomes for Targeted Combination Chemotherapy. Cancers. 12. PMID 33142721 DOI: 10.3390/cancers12113211   
2020 Gu W, Meng F, Haag R, Zhong Z. Actively targeted nanomedicines for precision cancer therapy: Concept, construction, challenges and clinical translation. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 33022328 DOI: 10.1016/j.jconrel.2020.10.003   
2020 Mirhadi E, Mashreghi M, Faal Maleki M, Alavizadeh SH, Arabi L, Badiee A, Jaafari MR. Redox-sensitive nanoscale drug delivery systems for cancer treatment. International Journal of Pharmaceutics. 589: 119882. PMID 32941986 DOI: 10.1016/j.ijpharm.2020.119882   
2020 He B, Sui X, Yu B, Wang S, Shen Y, Cong H. Recent advances in drug delivery systems for enhancing drug penetration into tumors. Drug Delivery. 27: 1474-1490. PMID 33100061 DOI: 10.1080/10717544.2020.1831106   
2020 Qin S, Jiang J, Lu Y, Nice EC, Huang C, Zhang J, He W. Emerging role of tumor cell plasticity in modifying therapeutic response. Signal Transduction and Targeted Therapy. 5: 228. PMID 33028808 DOI: 10.1038/s41392-020-00313-5   
2020 Jiang M, Li W, Zhu C, Li X, Zhang J, Luo Z, Qin B, Du Y, Luo L, You J. Perdurable PD-1 blockage awakes anti-tumor immunity suppressed by precise chemotherapy. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 33091531 DOI: 10.1016/j.jconrel.2020.10.031   
2020 Smalley M, Natarajan SK, Mondal J, Goldman D, Shanthappa B, Pellowe M, Dash C, Saha T, Khiste S, Ramadurai N, Eton EO, Smalley JL, Brown A, Thayakumar A, Rahman M, et al. Nano-Engineered Disruption of Heat shock protein 90 (Hsp90) Targets Drug-Induced Resistance and Relieves Natural Killer Cell Suppression in Breast Cancer. Cancer Research. PMID 33077554 DOI: 10.1158/0008-5472.CAN-19-4036   
2020 Xu B, Zhou W, Cheng L, Zhou Y, Fang A, Jin C, Zeng J, Song X, Guo X. Novel Polymeric Hybrid Nanocarrier for Curcumin and Survivin shRNA Co-delivery Augments Tumor Penetration and Promotes Synergistic Tumor Suppression. Frontiers in Chemistry. 8: 762. PMID 33134256 DOI: 10.3389/fchem.2020.00762   
2020 Ingram N, McVeigh LE, Abou-Saleh RH, Maynard J, Peyman SA, McLaughlan JR, Fairclough M, Marston G, Valleley EMA, Jimenez-Macias JL, Charalambous A, Townley W, Haddrick M, Wierzbicki A, Wright A, et al. Ultrasound-triggered therapeutic microbubbles enhance the efficacy of cytotoxic drugs by increasing circulation and tumor drug accumulation and limiting bioavailability and toxicity in normal tissues. Theranostics. 10: 10973-10992. PMID 33042265 DOI: 10.7150/thno.49670   
2020 Wang B, Sun L, Zhao J, An J, Jin Y, Yang X, Li H, Zhang H, Zhang Z, Youmei A. Limiting tumor cells comprehensively at micro and macro levels to improve the therapeutic effect of chemotherapy. Nanotechnology. 32: 015301. PMID 33078716 DOI: 10.1088/1361-6528/abb48f   
2020 Al-Zu'bi M, Mohan A. Modelling of combination therapy using implantable anticancer drug delivery with thermal ablation in solid tumor. Scientific Reports. 10: 19366. PMID 33168846 DOI: 10.1038/s41598-020-76123-0   
2020 Fischer C, Munks MW, Hill AB, Kroczek RA, Bissinger S, Brand V, Schmittnaegel M, Imhof-Jung S, Hoffmann E, Herting F, Klein C, Knoetgen H. Vaccine-induced CD8 T cells are redirected with peptide-MHC class I-IgG antibody fusion proteins to eliminate tumor cells in vivo. Mabs. 12: 1834818. PMID 33151105 DOI: 10.1080/19420862.2020.1834818   
2020 Zhang Y, Guo C, Liu L, Xu J, Jiang H, Li D, Lan J, Li J, Yang J, Tu Q, Sun X, Alamgir M, Chen X, Shen G, Zhu J, et al. ZnO-based multifunctional nanocomposites to inhibit progression and metastasis of melanoma by eliciting antitumor immunity via immunogenic cell death. Theranostics. 10: 11197-11214. PMID 33042278 DOI: 10.7150/thno.44920   
2020 Prabhu VV, Morrow S, Rahman Kawakibi A, Zhou L, Ralff M, Ray J, Jhaveri A, Ferrarini I, Lee Y, Parker C, Zhang Y, Borsuk R, Chang WI, Honeyman JN, Tavora F, et al. ONC201 and imipridones: Anti-cancer compounds with clinical efficacy. Neoplasia (New York, N.Y.). 22: 725-744. PMID 33142238 DOI: 10.1016/j.neo.2020.09.005   
2020 Demmers LC, Kretzschmar K, Van Hoeck A, Bar-Epraïm YE, van den Toorn HWP, Koomen M, van Son G, van Gorp J, Pronk A, Smakman N, Cuppen E, Clevers H, Heck AJR, Wu W. Single-cell derived tumor organoids display diversity in HLA class I peptide presentation. Nature Communications. 11: 5338. PMID 33087703 DOI: 10.1038/s41467-020-19142-9   
2020 Qiu Y, Sun J, Qiu J, Chen G, Wang X, Mu Y, Li K, Wang W. Antitumor Activity of Cabazitaxel and MSC-TRAIL Derived Extracellular Vesicles in Drug-Resistant Oral Squamous Cell Carcinoma. Cancer Management and Research. 12: 10809-10820. PMID 33149686 DOI: 10.2147/CMAR.S277324   
2020 Pimentel VO, Yaromina A, Marcus D, Dubois LJ, Lambin P. A novel co-culture assay to assess anti-tumor CD8 T cell cytotoxicity via luminescence and multicolor flow cytometry. Journal of Immunological Methods. 112899. PMID 33068606 DOI: 10.1016/j.jim.2020.112899   
2020 Wu F, Cheng Y, Wu L, Zhang W, Zheng W, Wang Q, Cao H, Pan X, Tang W. Emerging Landscapes of Tumor Immunity and Metabolism. Frontiers in Oncology. 10: 575037. PMID 33117713 DOI: 10.3389/fonc.2020.575037   
2020 Zhang J. Targeting mTOR by CZ415 Suppresses Cell Proliferation and Promotes Apoptosis via Lipin-1 in Cervical Cancer In Vitro and In Vivo. Reproductive Sciences (Thousand Oaks, Calif.). PMID 32944878 DOI: 10.1007/s43032-020-00313-4   
2020 Shofolawe-Bakare OT, Stokes LD, Hossain M, Smith AE, Werfel TA. Immunostimulatory biomaterials to boost tumor immunogenicity. Biomaterials Science. 8: 5516-5537. PMID 33049007 DOI: 10.1039/d0bm01183e   
2020 Weddell J, Chiney MS, Bhatnagar S, Gibbs JP, Shebley M. Mechanistic Modeling of Intra-Tumor Spatial Distribution of Antibody-Drug Conjugates: Insights into Dosing Strategies in Oncology. Clinical and Translational Science. PMID 33073529 DOI: 10.1111/cts.12892   
2020 Chen Z, Zhou L, Liu L, Hou Y, Xiong M, Yang Y, Hu J, Chen K. Single-cell RNA sequencing highlights the role of inflammatory cancer-associated fibroblasts in bladder urothelial carcinoma. Nature Communications. 11: 5077. PMID 33033240 DOI: 10.1038/s41467-020-18916-5   
2020 Gu Z, Da Silva CG, Van der Maaden K, Ossendorp F, Cruz LJ. Liposome-Based Drug Delivery Systems in Cancer Immunotherapy. Pharmaceutics. 12. PMID 33158166 DOI: 10.3390/pharmaceutics12111054   
2020 Tu B, He Y, Chen B, Wang Y, Gao Y, Shi M, Liu T, Asrorov AM, Huang Y. Deformable liposomal codelivery of vorinostat and simvastatin promotes antitumor responses through remodeling tumor microenvironment. Biomaterials Science. PMID 33169732 DOI: 10.1039/d0bm01516d   
2020 Dorjsuren B, Chaurasiya B, Ye Z, Liu Y, Li W, Wang C, Shi D, Evans CE, Webster TJ, Shen Y. Cetuximab-Coated Thermo-Sensitive Liposomes Loaded with Magnetic Nanoparticles and Doxorubicin for Targeted EGFR-Expressing Breast Cancer Combined Therapy. International Journal of Nanomedicine. 15: 8201-8215. PMID 33122906 DOI: 10.2147/IJN.S261671   
2020 Wang G, Wu B, Li Q, Chen S, Jin X, Liu Y, Zhou Z, Shen Y, Huang P. Active Transportation of Liposome Enhances Tumor Accumulation, Penetration, and Therapeutic Efficacy. Small (Weinheim An Der Bergstrasse, Germany). e2004172. PMID 33030305 DOI: 10.1002/smll.202004172   
2020 Gardell JL, Matsumoto LR, Chinn H, DeGolier KR, Kreuser SA, Prieskorn B, Balcaitis S, Davis A, Ellenbogen RG, Crane CA. Human macrophages engineered to secrete a bispecific T cell engager support antigen-dependent T cell responses to glioblastoma. Journal For Immunotherapy of Cancer. 8. PMID 33122397 DOI: 10.1136/jitc-2020-001202   
2020 Feng B, Chen K, Zhang W, Zheng Q, He Y. circPGAM1 enhances autophagy signaling during laryngocarcinoma drug resistance by regulating miR-376a. Biochemical and Biophysical Research Communications. PMID 33121682 DOI: 10.1016/j.bbrc.2020.10.063   
2020 Wang X, Zheng Y, Bao C, Zhong G, Liu S, Wiradharma N, Fan W, Yang YY, Wang X, Huang Y. Branched α-helical peptides enhanced antitumor efficacy and selectivity. Biomaterials Science. PMID 33029595 DOI: 10.1039/d0bm00629g   
2020 Schepisi G, Conteduca V, Casadei C, Gurioli G, Rossi L, Gallà V, Cursano MC, Brighi N, Lolli C, Menna C, Farolfi A, Burgio SL, Altavilla A, Martinelli G, De Giorgi U. Potential Application of Chimeric Antigen Receptor (CAR)-T Cell Therapy in Renal Cell Tumors. Frontiers in Oncology. 10: 565857. PMID 33072597 DOI: 10.3389/fonc.2020.565857   
2020 Ernst A, Hennel R, Krombach J, Kapfhammer H, Brix N, Zuchtriegel G, Uhl B, Reichel CA, Frey B, Gaipl US, Winssinger N, Shirasawa S, Sasazuki T, Sperandio M, Belka C, et al. Priming of Anti-tumor Immune Mechanisms by Radiotherapy Is Augmented by Inhibition of Heat Shock Protein 90. Frontiers in Oncology. 10: 1668. PMID 32984042 DOI: 10.3389/fonc.2020.01668   
2020 Richard V, Kumar TRS, Pillai RM. Transitional dynamics of cancer stem cells in invasion and metastasis. Translational Oncology. 14: 100909. PMID 33049522 DOI: 10.1016/j.tranon.2020.100909   
2020 Moghaddam SV, Abedi F, Alizadeh E, Baradaran B, Annabi N, Akbarzadeh A, Davaran S. Lysine-embedded cellulose-based nanosystem for efficient dual-delivery of chemotherapeutics in combination cancer therapy. Carbohydrate Polymers. 250: 116861. PMID 33049815 DOI: 10.1016/j.carbpol.2020.116861   
2020 García-Heredia JM, Otero-Albiol D, Pérez M, Pérez-Castejón E, Muñoz-Galván S, Carnero A. Breast tumor cells promotes the horizontal propagation of EMT, stemness, and metastasis by transferring the MAP17 protein between subsets of neoplastic cells. Oncogenesis. 9: 96. PMID 33106480 DOI: 10.1038/s41389-020-00280-0   
2020 Sharma A, Liaw K, Sharma R, Spriggs T, Appiani La Rosa S, Kannan S, Kannan RM. Dendrimer-Mediated Targeted Delivery of Rapamycin to Tumor-Associated Macrophages Improves Systemic Treatment of Glioblastoma. Biomacromolecules. PMID 33112134 DOI: 10.1021/acs.biomac.0c01270   
2020 Sanchez CE, Dowlati EP, Geiger AE, Chaudhry K, Tovar MA, Bollard CM, Cruz CRY. K Cell Adoptive Immunotherapy of Cancer: Evaluating Recognition Strategies and Overcoming Limitations. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 33007496 DOI: 10.1016/j.bbmt.2020.09.030   
2020 Kim MY, Shin JY, Kim JO, Son KH, Kim YS, Jung CK, Kang JH. Anti-tumor efficacy of CKD-516 in combination with radiation in xenograft mouse model of lung squamous cell carcinoma. Bmc Cancer. 20: 1057. PMID 33143663 DOI: 10.1186/s12885-020-07566-x   
2020 Fozzatti L, Cheng SY. Tumor Cells and Cancer-Associated Fibroblasts: A Synergistic Crosstalk to Promote Thyroid Cancer. Endocrinology and Metabolism (Seoul, Korea). PMID 33161690 DOI: 10.3803/EnM.2020.401   
2020 Lu YB, Sun TJ, Chen YT, Cai ZY, Zhao JY, Miao F, Yang YN, Wang SX. Targeting the Epithelial-to-Mesenchymal Transition in Cancer Stem Cells for a Better Clinical Outcome of Glioma. Technology in Cancer Research & Treatment. 19: 1533033820948053. PMID 33089751 DOI: 10.1177/1533033820948053   
2020 Peng H, Wang JH, Guo F, Zhu FF, Wen ZJ, Zhong HJ, Liang DS. Legumain protease-activated tuftsin-functionalized nanoparticles for dual-targeting TAMs and cancer chemotherapy. Colloids and Surfaces. B, Biointerfaces. 197: 111442. PMID 33166937 DOI: 10.1016/j.colsurfb.2020.111442   
2020 Huang LT, Tsai CL, Huang SH, Chang MM, Chang WT, Cheng LH, Cheng HC. Depleting RhoA/Stress Fiber-Organized Fibronectin Matrices on Tumor Cells Non-Autonomously Aggravates Fibroblast-Driven Tumor Cell Growth. International Journal of Molecular Sciences. 21. PMID 33158289 DOI: 10.3390/ijms21218272   
2020 Zhang LN, Zhang DD, Yang L, Gu YX, Zuo QP, Wang HY, Xu J, Liu DX. Roles of cell fusion between mesenchymal stromal/stem cells and malignant cells in tumor growth and metastasis. The Febs Journal. PMID 33070450 DOI: 10.1111/febs.15483   
2020 Bou-Gharios J, Assi S, Bahmad HF, Kharroubi H, Araji T, Chalhoub RM, Ballout F, Harati H, Fares Y, Abou-Kheir W. The potential use of tideglusib as an adjuvant radio-therapeutic treatment for glioblastoma multiforme cancer stem-like cells. Pharmacological Reports : Pr. PMID 33140310 DOI: 10.1007/s43440-020-00180-5   
2020 Sharma P, Sonawane P, Herpai D, D'Agostino R, Rossmeisl J, Tatter S, Debinski W. Multireceptor targeting of glioblastoma. Neuro-Oncology Advances. 2: vdaa107. PMID 33150335 DOI: 10.1093/noajnl/vdaa107   
2020 Han J, Gao L, Wang J, Wang J. Application and development of aptamer in cancer: from clinical diagnosis to cancer therapy. Journal of Cancer. 11: 6902-6915. PMID 33123281 DOI: 10.7150/jca.49532   
2020 Pires A, Greenshields-Watson A, Jones E, Smart K, Lauder SN, Somerville M, Milutinovic S, Kendrick H, Hindley JP, French R, Smalley MJ, Watkins WJ, Andrews R, Godkin A, Gallimore A. Immune Remodelling of the Extracellular Matrix Drives Loss of Cancer Stem Cells and Tumor Rejection. Cancer Immunology Research. PMID 33023965 DOI: 10.1158/2326-6066.CIR-20-0070   
2020 Ghosh S, Dutta S, Sarkar A, Kundu M, Sil PC. Targeted delivery of curcumin in breast cancer cells via hyaluronic acid modified mesoporous silica nanoparticle to enhance anticancer efficiency. Colloids and Surfaces. B, Biointerfaces. 197: 111404. PMID 33142257 DOI: 10.1016/j.colsurfb.2020.111404   
2020 Buyandelger B, Bar EE, Hung KS, Chen RM, Chiang YH, Liou JP, Huang HM, Wang JY. Histone deacetylase inhibitor MPT0B291 suppresses Glioma Growth and partially through acetylation of p53. International Journal of Biological Sciences. 16: 3184-3199. PMID 33162824 DOI: 10.7150/ijbs.45505   
2020 Guo R, Chu A, Gong Y. Identification of cancer stem cell-related biomarkers in intestinal-type and diffuse-type gastric cancer by stemness index and weighted correlation network analysis. Journal of Translational Medicine. 18: 418. PMID 33160391 DOI: 10.1186/s12967-020-02587-3   
2020 Chen YY, Lo CF, Chiu TY, Hsu CY, Yeh TK, Chen CP, Huang CL, Huang CY, Wang MH, Huang YC, Ho HH, Chao YS, Shih JC, Tsou LK, Chen CT. BPRDP056, a novel small molecule drug conjugate specifically targeting phosphatidylserine for cancer therapy. Translational Oncology. 14: 100897. PMID 33069101 DOI: 10.1016/j.tranon.2020.100897